<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-510" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Poikiloderma Congenitale</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hafsi</surname>
            <given-names>Wissem</given-names>
          </name>
          <aff>Faculty of Medicine of Tunis, Tunisia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Badri</surname>
            <given-names>Talel</given-names>
          </name>
          <aff>University of Tunis El Manar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Wissem Hafsi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Talel Badri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-510.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Congenital poikiloderma, or Rothmund-Thomson syndrome (RTS), is a rare genodermatosis with autosomal recessive inheritance. It is characterized by early-onset facial poikiloderma and associated with clinical features, including short stature, sparse scalp hair, absent or sparse eyelashes or eyebrows, juvenile cataracts, skeletal abnormalities, premature aging, and susceptibility to osteosarcoma. There are 2 types of congenital poikiloderma. Type 1 is characterized by rapidly progressive, bilateral, juvenile cataracts. In contrast, type 2 is characterized by congenital bone abnormalities and an increased risk of osteosarcoma in childhood and squamous cell carcinoma at an older age. This activity reviews the presentation, evaluation, and management of congenital poikiloderma and stresses the role of an interprofessional team approach to the care of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of congenital poikiloderma.</p></list-item><list-item><p>Assess&#x000a0;the history and physical exam findings typically seen in patients with congenital poikiloderma.</p></list-item><list-item><p>Evaluate&#x000a0;the management of congenital poikiloderma.</p></list-item><list-item><p>Communicate&#x000a0;the modalities to improve care coordination among interprofessional team members to improve outcomes for patients affected by congenital poikiloderma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=510&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=510">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-510.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Congenital poikiloderma, also known as Rothmund-Thomson syndrome (RTS), is a rare genodermatosis of autosomal recessive (AR) inheritance characterized by a typical erythema facial (poikiloderma) of early-onset, associated with different clinical features including short stature, sparse scalp hair, absent or sparse eyelashes or eyebrows, juvenile cataracts, skeletal abnormalities, juvenile cataract, premature aging, and susceptibility to osteosarcoma. See <bold>Image.</bold>&#x000a0;Poikiloderma Congenitale. There are 2 types of RTS. Type 1 is characterized by rapidly progressive, bilateral, juvenile cataracts. In contrast, congenital bone abnormalities and an increased risk of osteosarcoma in childhood and squamous cell carcinoma at an older age characterize type 2.<xref ref-type="bibr" rid="article-510.r1">[1]</xref><xref ref-type="bibr" rid="article-510.r2">[2]</xref></p>
      </sec>
      <sec id="article-510.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The gene responsible for&#x000a0;type 1&#x000a0;RTS has not yet been found.&#x000a0;Type 2 RTS&#x000a0;is due to homozygous or heterozygous composite mutations of the <italic toggle="yes">RECQL4</italic> gene of the RecQ-helicase family (8q24.3, detected in 60% to 65% of patients). The <italic toggle="yes">RECQL4</italic> gene encodes a protein DNA helicase RecQ involved in the replication and repair of DNA and telomeres.<xref ref-type="bibr" rid="article-510.r2">[2]</xref></p>
      </sec>
      <sec id="article-510.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of congenital&#x000a0;poikiloderma is unknown, but about 300 cases have been described in the literature, and type 2&#x000a0;RTS accounts for almost two-thirds of cases. Given the&#x000a0;AR inheritance, most reported cases were isolated, but cases involving more than&#x000a0;1 person in the same family were also reported. The gender ratio equals 1, but a male or female predominance has been noted in some series. Finally,&#x000a0;congenital&#x000a0;poikiloderma&#x000a0;has been reported in all ethnic groups.<xref ref-type="bibr" rid="article-510.r2">[2]</xref></p>
      </sec>
      <sec id="article-510.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p><italic toggle="yes">RECQL4,</italic> whose mutation is responsible for most congenital&#x000a0;poikiloderma cases, belongs to the RECQ DNA helicase family. In this family, gene mutations&#x000a0;<italic toggle="yes">RECQL2</italic> (BLM), <italic toggle="yes">WRN,</italic> and <italic toggle="yes">RECQL4</italic> are responsible for Bloom, Werner, and type 2 RTS,&#x000a0;respectively. The origin of type 1&#x000a0;RTS is still unknown. The protein product of <italic toggle="yes">RECQL4</italic> plays an essential role in maintaining the integrity of the human genome. Indeed, it is essential in DNA replication, damage repair, homologous recombination, and maintenance of mitochondrial and telomere DNA integrity. The alteration of these functions is at the origin of the poikiloderma, premature age, and different clinical features that characterize congenital&#x000a0;poikiloderma. Apart from&#x000a0;type 2 RTS, the mutation of the same gene <italic toggle="yes">RECQL4</italic> is at the origin of 2 other rare syndromes, namely Baller-Gerold syndrome and RAPADILINO syndrome, which have common signs.<xref ref-type="bibr" rid="article-510.r1">[1]</xref><xref ref-type="bibr" rid="article-510.r2">[2]</xref></p>
      </sec>
      <sec id="article-510.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>In cases of histological examination of a skin specimen,&#x000a0;one finds the usual signs of poikiloderma, namely hyperkeratosis, epidermal atrophy, vacuolization of the basal layer, rare apoptotic bodies, many telangiectatic vessels, pigment incontinence with dermal melanophages, and an inflammatory infiltrate of the superficial dermis. Biopsy of verrucous lesions shows significant hyperkeratosis, normal or thickened epidermis, and dyskeratotic cells.<xref ref-type="bibr" rid="article-510.r2">[2]</xref></p>
      </sec>
      <sec id="article-510.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The dermatologist generally&#x000a0;suspects the diagnosis of congenital poikiloderma since the first clinical signs of this syndrome affect organs of ectodermal and mesodermal origin, namely skin, hair, nails, and teeth. The involvement of other organs is rarer and later.</p>
        <p>
<bold>Skin Features</bold>
</p>
        <p>The skin is usually normal at birth, but erythema of the cheeks appears between the third and sixth month of life and then extends to the extremities and possibly to the buttocks. The trunk and abdomen are usually spared. In the case of intense erythema, swelling and blistering can appear. The evolution is towards punctate skin atrophy with reticular hypo- and hyperpigmentation and the development of permanent telangiectasias, realizing the typical appearance of poikiloderma that persists throughout life. Recognition of the age of onset, evolution, and stabilization of this poikiloderma may be an important argument for differentiating&#x000a0;RTS from other syndromes that include poikilothermic features. Later, there may be latte milk cafe&#x000a0;au lait spots. Premature&#x000a0;aging&#x000a0;of the skin has been reported in some subjects. One-third of individuals had hyperkeratotic palmoplantar lesions. Sparse, thin, or absent hair on the scalp, eyebrows, or eyelashes are common signs. Nail anomalies such as dystrophy or pachyonychia are also frequent. Dental abnormalities are usual and include microdontia, rudimentary teeth, crown formations, and an increased incidence of caries.</p>
        <p>
<bold>Ocular Involvement</bold>
</p>
        <p>Bilateral cataracts are the most common ocular sign and develop in the first years of life. They are subcapsular, can lead to blindness, and characterize type 1 RTS. Other ocular abnormalities have been reported, including corneal atrophy, exophthalmia, congenital bilateral glaucoma, retinal atrophy, strabismus, photophobia, and blue sclerae.</p>
        <p>
<bold>Skeletal Abnormalities</bold>
</p>
        <p>They are common (68% in the literature), including saddle noses, frontal bossing, and abnormalities of the long bones. All patients with bone abnormalities had <italic toggle="yes">a RECQL4</italic> mutation that explains the predisposition of this mutation to osteosarcoma development.</p>
        <p>
<bold>Systemic Manifestations</bold>
</p>
        <p>They include growth anomalies with low birth weight and short stature, mental retardation, and sensorineural deafness, anomalies of the gastrointestinal system such as pyloric stenosis and anal atresia, bronchiectasis with an increased incidence of lower respiratory tract infections, hematological signs such as progressive leukopenia and chronic hypochromic anemia.<xref ref-type="bibr" rid="article-510.r1">[1]</xref><xref ref-type="bibr" rid="article-510.r3">[3]</xref><xref ref-type="bibr" rid="article-510.r4">[4]</xref><xref ref-type="bibr" rid="article-510.r5">[5]</xref><xref ref-type="bibr" rid="article-510.r6">[6]</xref></p>
        <p>
<bold>Malignancies</bold>
</p>
        <p>The major risk in&#x000a0;congenital&#x000a0;poikiloderma is the development of neoplasia, which is life-threatening. Bone (30%) and skin (5%) cancers are the most common. Osteosarcoma is the most common mesenchymal cancer. It has the same characteristics as the sporadic bone but of earlier onset (14 versus 17 years). Cases of multiple&#x000a0;osteosarcomas&#x000a0;have been reported with a more frequent incidence than sporadic&#x000a0;osteosarcoma&#x000a0;(17.9 to 25.6% versus 0.4% to 10%). The most common skin cancer is squamous cell carcinoma. Other skin cancers (basal cell carcinoma, Bowen disease, melanoma), hematologic (myelodysplasia, Hodgkin and non-Hodgkin lymphomas, acute myeloid leukemia), and visceral (fibrosarcoma, gastric carcinoma) have been reported rarely.<xref ref-type="bibr" rid="article-510.r7">[7]</xref><xref ref-type="bibr" rid="article-510.r8">[8]</xref><xref ref-type="bibr" rid="article-510.r9">[9]</xref><xref ref-type="bibr" rid="article-510.r10">[10]</xref></p>
      </sec>
      <sec id="article-510.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Histological examination of the cutaneous lesions is not necessary. This diagnostic contribution is modest. Radiological investigation of skeletal abnormalities should be systematic because clinical examination may not detect them. Data from the anamnesis and clinical examination guide the rest of the biological and radiological explorations.</p>
      </sec>
      <sec id="article-510.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of congenital&#x000a0;poikiloderma requires long-term follow-up, which is performed by an interprofessional team, including a dermatologist, an ophthalmologist, an oncologist, and an orthopedic surgeon. The surveillance is done at least twice a year, looking for skin changes, a cataract, or a bone tumor. Treating skin manifestations must be preventive by effective external photoprotection, including wearing long sleeves, applying sunscreens with a high protection index, and adopting&#x000a0;healthy behavior to avoid maximum sun exposure. The telangiectasias already shown can be treated by the pulsed dye laser. Cataract treatment is surgical. The orthopedic surgeon and the oncologist should discuss and manage bone tumors. Other abnormalities that can be seen in the RTS, namely stomatological and respiratory abnormalities, require specialized and early management.<xref ref-type="bibr" rid="article-510.r7">[7]</xref><xref ref-type="bibr" rid="article-510.r8">[8]</xref><xref ref-type="bibr" rid="article-510.r9">[9]</xref></p>
      </sec>
      <sec id="article-510.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The diagnosis of congenital poikiloderma is not always obvious. Some genodermatoses may have a fairly similar clinical presentation&#x000a0;with a poikiloderma. The differential diagnosis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bloom syndrome (AR)</p>
          </list-item>
          <list-item>
            <p>Werner syndrome (AR)</p>
          </list-item>
          <list-item>
            <p>Cockayne syndrome</p>
          </list-item>
          <list-item>
            <p>Xeroderma pigmentosum (AR)</p>
          </list-item>
          <list-item>
            <p>Fanconi anemia (AR)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-510.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis is variable. Life expectancy is normal if there is no cancer; whereas, the evolution of patients with malignant diseases depends on the quality and frequency of cancer screening and treatment. Patients with type 2&#x000a0;RTS should be monitored regularly because of the increased risk of developing cancer. Management includes laser treatment of telangiectatic lesions, annual ophthalmologic examination, and radiological examination for bone pain, lameness, or fracture suggestive of osteosarcoma. Increased sensitivity to the effects of chemotherapy is suspected, with a risk of secondary malignancy (risk of 5% of developing skin cancer).<xref ref-type="bibr" rid="article-510.r7">[7]</xref><xref ref-type="bibr" rid="article-510.r9">[9]</xref></p>
      </sec>
      <sec id="article-510.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The primary complication accompanying&#x000a0;RTS is cancer susceptibility.<xref ref-type="bibr" rid="article-510.r11">[11]</xref></p>
      </sec>
      <sec id="article-510.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with congenital poikiloderma need to understand that sun exposure increases their risk of skin cancer. Therefore, sun exposure protection is crucial, including remaining in full shade, wearing clothing that covers the exposed skin, and using broad-spectrum sunscreens. Blindness secondary to cataract development is another potential complication. Genetic counseling is also&#x000a0;a consideration for family members.</p>
      </sec>
      <sec id="article-510.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>There is a problem of genotype/phenotype correlation in the congenital poikiloderma or&#x000a0;RTS group. The mutation of the&#x000a0;<italic toggle="yes">RECQL4</italic>&#x000a0;gene was not detected in type 1 RTS, and it was only detected in two-thirds of type 2&#x000a0;RTS cases. The risk of osteosarcoma is associated with type 2 RTS. According to many studies, it is directly associated with at least&#x000a0;1 mutation of the <italic toggle="yes">RECQL4</italic> gene since this mutation is not detected in a third of cases. It is now known that&#x000a0;there are other syndromes associated with a mutation of the same gene, namely the RAPADILINO syndrome, in which the risk of cancer is much lower. Cataract characterizes type 1 RTS, but the mutation related to this association is not yet identified.</p>
      </sec>
      <sec id="article-510.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Congenital poikiloderma is a rare genetic disease that requires early diagnosis and adequate multispecialty management. The dermatologist's role is important because the poikiloderma is a fundamental sign that allows them to suspect the diagnosis. The advice on effective and long-term photoprotection is of major importance. The early detection of cataracts and their adequate management by the ophthalmologist in type 1&#x000a0;RTS is necessary to avoid the evolution towards blindness with its heavy consequences both medically and socially. Also, screening for bone abnormalities in type 2&#x000a0;RTS is fundamental. This has consequences on the musculoskeletal system, but above all, a predictive value on the occurrence of osteosarcoma is the major risk in type 2 RTS. Diagnosing this neoplasia and its treatment by orthopedists must be early and adequate. Psychological care is also critical since the disease can alter the patient's quality of life. Nurses and primary care clinicians must be aware of the disease and treatment to support the patient and their families appropriately.</p>
      </sec>
      <sec id="article-510.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=510&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=510">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/poikiloderma-congenitale-rothmund-thomson-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=510">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/510/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=510">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-510.s17">
        <fig id="article-510.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Poikiloderma Congenitale Contributed by K Humphreys</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Poikiloderma__Congenitale" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-510.s18">
        <title>References</title>
        <ref id="article-510.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colombo</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Locatelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cubells S&#x000e1;nchez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Romeo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elcioglu</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Maystadt</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Esteve Mart&#x000ed;nez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sironi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fontana</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Finelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gervasini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pecile</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Larizza</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Rothmund-Thomson Syndrome: Insights from New Patients on the Genetic Variability Underpinning Clinical Presentation and Cancer Outcome.</article-title>
            <source>Int J Mol Sci</source>
            <year>2018</year>
            <month>Apr</month>
            <day>06</day>
            <volume>19</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">29642415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manavi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>Rothmund-Thomson syndrome.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>518</fpage>
            <page-range>518-9</page-range>
            <pub-id pub-id-type="pmid">25396146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salih</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Onwuzurike</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Rothmund-Thomson syndrome (RTS) with osteosarcoma due to <italic>RECQL4</italic> mutation.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Jan</month>
            <day>23</day>
            <volume>2018</volume>
            <pub-id pub-id-type="pmid">29367366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chinmayee</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Meghana</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Prathiba</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Ramesh</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic manifestations in Rothmund-Thomson syndrome: Case report and review of literature.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>10</issue>
            <fpage>1025</fpage>
            <page-range>1025-1027</page-range>
            <pub-id pub-id-type="pmid">29044077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Rare presentation of Rothmund-Thomson syndrome with predominantly cutaneous findings.</article-title>
            <source>JAAD Case Rep</source>
            <year>2017</year>
            <month>May</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>172</fpage>
            <page-range>172-174</page-range>
            <pub-id pub-id-type="pmid">28443301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r6">
          <label>6</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Wang</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Plon</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <chapter-title>Rothmund-Thomson Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1999</year>
            <month>10</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">20301415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miranda</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Rivera-Monge</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Farias</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Rothmund-Thomson syndrome and ocular surface findings: case reports and review of the literature.</article-title>
            <source>Arq Bras Oftalmol</source>
            <year>2016</year>
            <season>May-Jun</season>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>186</fpage>
            <page-range>186-8</page-range>
            <pub-id pub-id-type="pmid">27463631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zils</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Klingebiel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Behnisch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Schlegel</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Fruehwald</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suttorp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bielack</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Osteosarcoma in patients with Rothmund-Thomson syndrome.</article-title>
            <source>Pediatr Hematol Oncol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-40</page-range>
            <pub-id pub-id-type="pmid">25551679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerrero-Gonz&#x000e1;lez</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Cabriales</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Ju&#x000e1;rez</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>de Jes&#x000fa;s Lugo-Trampe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Espinoza-Gonz&#x000e1;lez</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Flores</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ocampo-Candiani</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Rothmund-thomson syndrome: a 13-year follow-up.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2014</year>
            <month>May</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>176</fpage>
            <page-range>176-9</page-range>
            <pub-id pub-id-type="pmid">25120469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larizza</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roversi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Volpi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Rothmund-Thomson syndrome.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2010</year>
            <month>Jan</month>
            <day>29</day>
            <volume>5</volume>
            <fpage>2</fpage>
            <pub-id pub-id-type="pmid">20113479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-510.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narayan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trainer</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Rothmund-Thomson syndrome with myelodysplasia.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2001</year>
            <season>May-Jun</season>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>210</fpage>
            <page-range>210-2</page-range>
            <pub-id pub-id-type="pmid">11438000</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
